A recent review highlighted that changes in molecular biomarkers such as C-reactive protein (CRP), interleukin 6 (IL-6) and IL-10 in blood, urine, and other body fluids are associated with post-stroke cognitive decline [47]. This evidence concerns the gene IL6 and stroke disorder.